DAPY derivatives (Fudan Univ/Rega)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameDAPY derivatives (Fudan Univ/Rega)
Drug Alias NameHIV-1 RT inhibitors (Fudan Univ/Rega)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFudan University
China Registration ClassN/A

Develop Information

Active CompaniesRega Institute for Medical ResearchFudan University
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A